Assessing post-operative complications after laparoscopic nephrectomy for kidney cancer
Study of Post-operative Complications After Laparoscopic Outpatient Nephrectomy in Patients With Localised Kidney Cancer
GCS Ramsay Santé pour l'Enseignement et la Recherche · NCT06532422
This study looks at the complications that might happen within a month after patients have outpatient laparoscopic surgery to remove a kidney due to cancer.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | GCS Ramsay Santé pour l'Enseignement et la Recherche (other) |
| Locations | 1 site (Lyon) |
| Trial ID | NCT06532422 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the incidence of post-operative complications occurring within one month following outpatient laparoscopic nephrectomy for localized kidney cancer. Adult patients scheduled for this procedure will be identified during their initial consultation with a urological surgeon. The study will involve monitoring these patients post-surgery to gather data on any complications that arise. It is a single-centre, non-comparative study designed to provide insights into the safety and outcomes of outpatient nephrectomy.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 with localized kidney cancer who are scheduled for outpatient laparoscopic nephrectomy.
Not a fit: Patients requiring emergency interventions or those not eligible for outpatient treatment may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of post-operative risks, leading to improved patient management and outcomes after nephrectomy.
How similar studies have performed: While similar studies have been conducted, this specific observational approach to outpatient nephrectomy complications is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over 18 ; * Localised kidney cancer ; * Validation of curative treatment at a multidisciplinary consultation meeting; * Partial or total laparoscopic nephrectomy scheduled on an outpatient basis; * Membership of a social security scheme or receiving State Medical Aid; * Patient able to understand the information relating to the study, to read the information leaflet and who has given his/her oral non-objection. Exclusion Criteria: * Emergency intervention ; * Patient not eligible for outpatient treatment; * Long-term curative anti-coagulant treatment ; * Resident more than 100km from the clinic; * Home alone on the first night; * Patient of protected age (under guardianship or curatorship, or deprived of liberty).
Where this trial is running
Lyon
- Clinique de la Sauvegarde — Lyon, France (RECRUITING)
Study contacts
- Study coordinator: Arnaud MD BALDINI
- Email: docteur.baldini@urolyon-ouest.fr
- Phone: 469001019
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Kidney Cancer